Literature DB >> 2339640

Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals.

J P Devogelaer1, C Nagant de Deuxchaisnes, F Stein.   

Abstract

The gastrointestinal absorption of enteric-coated (EC) tablets of sodium fluoride (NaF) with respect to different time schedules of administration of calcium supplements in solution was tested. It was found that the simultaneous administration of these two medications under these formulations did not interfere with fluoride absorption. The calcium was also well absorbed as shown by the rise in serum ionized calcium concentration. Other schedules were studied as well, such as EC NaF tablets taken 1 hour after or 3 hours before the administration of calcium supplements. No superiority was shown, on the contrary, compared with the simultaneous administration of both medications. It was concluded that EC tablets of NaF and calcium supplements in solution can be provided simultaneously to enhance compliance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339640     DOI: 10.1002/jbmr.5650051311

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

1.  Bioavailability of fluoride in postmenopausal women: comparative study between sodium fluoride and disodium monofluorophosphate-calcium carbonate.

Authors:  F Lioté; C Bardin; A Liou; A Brouard; J L Terrier; D Kuntz
Journal:  Calcif Tissue Int       Date:  1992-03       Impact factor: 4.333

2.  Mineral density gain in vertebrae of osteoporotic women on oral pamidronate reverts a year after treatment discontinuance.

Authors:  J R Zanchetta; H Plotkin; E J Roldán
Journal:  Calcif Tissue Int       Date:  1996-07       Impact factor: 4.333

Review 3.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Comparison of serum fluoride levels after administration of monofluorophosphate-calcium carbonate or sodium fluoride: differences in peak serum concentrations.

Authors:  L Erlacher; H Teufelsbauer; P Bernecker; P Pietschmann; M Weissel
Journal:  Clin Investig       Date:  1994-12

Review 5.  Fluoride therapy of type I osteoporosis.

Authors:  J P Devogelaer; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.